CLINICAL24: Challenges, collaborations, and innovations in hematology
21 Oct 2024
Leadership perspectives: Andy Hay, President of Sysmex America Ltd., in discussion with Sonia Nicholas, SelectScience, discusses critical challenges facing laboratories, including staffing shortages, consolidation, and declining reimbursements. Plus, while COVID-19 briefly highlighted medical technology, it quickly faded from public focus. To overcome these hurdles, companies like Sysmex are focusing on automation, AI, and partnerships to improve care. A new frontier in neurology, especially in detecting diseases like Alzheimer's, is emerging. Hay believes that the industry's future lies in cross-functional collaborations and a balance between profitability and meaningful impact on patient care, aiming to shift from reactive to proactive healthcare.
This interview was recorded for #CLINICAL24 2024